See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

Perspective 1

Presenter: Jeff Davis

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: Technical and Biological Challenges for Future DCB Development

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology

Presenter: Rishi Puri

October 23, 2012

Presentation TCT 2012

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

CABG Will Always Be the Preferred Approach!

Presenter: Friedrich Mohr

October 23, 2012

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con!

Presenter: Alex Powell

October 23, 2012

Advertisement

Slides

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Perspective 1

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

State-of-the-Field Keynote: Technical and Biological Challenges for Future DCB Development

TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

CABG Will Always Be the Preferred Approach!

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content